Cell Therapy and Cryopreservation

Cell therapies with short shelf-life due to a “fresh” final product (as the product is not designed for a long-term storage) are perfectly acceptable for proof of concept of the cell therapy. But when it enters late-stage development and then commercial production, different constraints arise. Thus a cryopreserved final product becomes a necessity when considering the possibility of a late-stage clinical or commercial product with potentially thousands of doses a year that are needed to be shipped to different hospitals all over a continent or the world.

    Related Conference of Cell Therapy and Cryopreservation

    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    August 28-29, 2025

    12th World Congress on Epigenetics and Chromosome

    London, UK
    September 16-17, 2025

    5th Experts Meeting on Plant, Cellular and Molecular Biology

    Madrid, Spain
    September 25-26, 2025

    18th World Congress on Advances in Stem Cell Research and Regenerative Medicine

    Montreal, Canada
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain
    October 30-31, 2025

    Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

    Rome, Italy
    November 17-18, 2025

    18th International Conference on Human Genomics and Genomic Medicine

    Paris, France
    June 18-19, 2026

    16th International Conference on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Cell Therapy and Cryopreservation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in